These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12408049)

  • 1. Toll-like receptors and activation of autoreactive B cells.
    Leadbetter EA; Rifkin IR; Marshak-Rothstein A
    Curr Dir Autoimmun; 2003; 6():105-22. PubMed ID: 12408049
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites.
    Herlands RA; William J; Hershberg U; Shlomchik MJ
    Eur J Immunol; 2007 Dec; 37(12):3339-51. PubMed ID: 18034429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid factors in health and disease: structure, function, induction and regulation.
    Haberman AM; William J; Euler C; Shlomchik MJ
    Curr Dir Autoimmun; 2003; 6():169-95. PubMed ID: 12408052
    [No Abstract]   [Full Text] [Related]  

  • 4. B cell anergy and systemic lupus erythematosus.
    Seo SJ; Mandik-Nayak L; Erikson J
    Curr Dir Autoimmun; 2003; 6():1-20. PubMed ID: 12408044
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
    Leadbetter EA; Rifkin IR; Hohlbaum AM; Beaudette BC; Shlomchik MJ; Marshak-Rothstein A
    Nature; 2002 Apr; 416(6881):603-7. PubMed ID: 11948342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
    FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells.
    Rifkin IR; Leadbetter EA; Beaudette BC; Kiani C; Monestier M; Shlomchik MJ; Marshak-Rothstein A
    J Immunol; 2000 Aug; 165(3):1626-33. PubMed ID: 10903773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
    Tchorbanov AI; Voynova EN; Mihaylova NM; Todorov TA; Nikolova M; Yomtova VM; Chiang BL; Vassilev TL
    Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology: DNA drives autoimmunity.
    Vinuesa CG; Goodnow CC
    Nature; 2002 Apr; 416(6881):595-8. PubMed ID: 11948338
    [No Abstract]   [Full Text] [Related]  

  • 10. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells.
    Fields ML; Sokol CL; Eaton-Bassiri A; Seo S; Madaio MP; Erikson J
    J Immunol; 2001 Aug; 167(4):2370-8. PubMed ID: 11490027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactive B cells get activated in extrafollicular sites.
    Weisel F; Wellmann U; Winkler TH
    Eur J Immunol; 2007 Dec; 37(12):3330-3. PubMed ID: 18050163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
    He B; Qiao X; Cerutti A
    J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.
    Halcomb KE; Musuka S; Gutierrez T; Wright HL; Satterthwaite AB
    Mol Immunol; 2008 Dec; 46(2):233-41. PubMed ID: 18849077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
    Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
    J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of rheumatoid factor-specific B cells is antigen dependent and occurs preferentially outside of germinal centers in the lupus-prone NZM2410 mouse model.
    Sang A; Niu H; Cullen J; Choi SC; Zheng YY; Wang H; Shlomchik MJ; Morel L
    J Immunol; 2014 Aug; 193(4):1609-21. PubMed ID: 25015835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides.
    Brummel R; Lenert P
    J Immunol; 2005 Feb; 174(4):2429-34. PubMed ID: 15699180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immunity in the etiopathology of autoimmunity.
    Carroll M
    Nat Immunol; 2001 Dec; 2(12):1089-90. PubMed ID: 11725293
    [No Abstract]   [Full Text] [Related]  

  • 19. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.
    Lau CM; Broughton C; Tabor AS; Akira S; Flavell RA; Mamula MJ; Christensen SR; Shlomchik MJ; Viglianti GA; Rifkin IR; Marshak-Rothstein A
    J Exp Med; 2005 Nov; 202(9):1171-7. PubMed ID: 16260486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
    J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.